Dr. Morrisa Baskin, MD

Dr. Baskin practices at Confluence Health in Wenatchee, Washington.

Dr. Baskin's NPI, 1760418271, was assigned on June 25, 2006. Dr. Baskin graduated from Keck School of Medicine of USC in 1987. Dr. Baskin holds Washington license MD00029694.

Dr. Baskin's primary practice is Confluence Health, at 1201 N Miller St, Wenatchee, WA 98801 in Chelan County. The practice phone is (509) 662-1511.

Dr. Baskin's primary practice is Confluence Health in Wenatchee, Washington. Dr. Baskin is also affiliated with Confluence Health Hospital | Central Campus. The medical group on file is Confluence Health. Dmand AI also links Dr. Baskin to 2 more group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Baskin practices, 3 sites in all. Vendor and product names are available with a free account.

Dermatology is Dr. Baskin's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Baskin is board certified in dermatology by the American Board of Dermatology. Dr. Baskin is licensed in Washington.

Dmand AI lists acne, acute skin infection, benign or precancerous skin growths, cancerous skin growth removal, cold sores or genital herpes, contact dermatitis, itchy rashes and psoriasis among the conditions Dr. Baskin treats.

CMS data shows 5,101 Medicare services from Dr. Baskin across 16 procedure codes in 2024, for 985 Medicare patients. Medicare paid $114,802 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 985 Medicare patients who saw Dr. Baskin in 2024. The largest group is 75 to 84, with 446 patients. 64% of them have high cholesterol, and 62% have high blood pressure. 2% are also on Medicaid. Their average risk score is 0.94, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Baskin's median patient age at 71, with 59% women.

In 2024, Dr. Baskin wrote 983 Medicare Part D claims for 384 patients. 90% of them were for generic drugs. CMS names the drug for 824 of them, across 25 drugs with 11 or more claims each, at $474,961 in total drug cost. In 2023, CMS named 628 claims across 22 drugs.

Dr. Baskin accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 305 procedures of removal of skin lesions by Dr. Baskin, more than 82% of the clinicians it reports for that procedure.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Removal or shaving of skin growth: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links Dr. Baskin to 2 clinical trials. Conditions studied include Melanoma and Nevi and Melanomas.

CMS Open Payments shows 1 general payment to Dr. Baskin from 1 drug or device company in 2018. Food and beverage make up the largest share, 100% of the total. Allergan Inc. paid the most, $22.

Dmand AI lists 2 awards for Dr. Baskin, most recently CMS Stage 1 EHR in 2013.

Dr. Baskin graduated from Keck School of Medicine of USC in 1987. Dr. Baskin is a member of AAD.

Dr. Baskin is in network with 5 carriers, including Aetna, United Healthcare and Blue Cross Blue Shield of Michigan. HMO plans come from the most carriers, 4. Check the plan with the practice before a visit.